Skip to content
mapperlab
← Dashboard
Stock

MOH

MOLINA HEALTHCARE, INC.
Health CareManaged Health CareLatest close $18510 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
10
27 funds tracked
Ever held
14
Current + past
New this quarter
2
Exited this quarter
0

Marquee-fund ownership over time

Nov 14, 2014Aug 14, 2020Nov 14, 2023May 15, 2026
Now
10

This quarter's activity

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Maverick Capital re-entered$127$185+46%
Bridgewater Associates re-entered$296$185-38%
Renaissance Technologies$338$185-45%
Citadel Advisors re-entered$339$185-45%
Two Sigma Investments re-entered$339$185-45%
D.E. Shaw$339$185-45%
AQR Capital Management$339$185-45%
Millennium Management$339$185-45%
Scion Asset Management re-entered$339$185-45%
Point72 Asset Management re-entered$306$185-40%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Viking Global Investors 4× in & out→ $138-14%
Glenview Capital→ $308+70%
Coatue Management→ $181+25%
JANA Partners→ $85+48%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at MOLINA HEALTHCARE, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
3
Filings · last 90d
18
Total on file
637
Recent SEC buffer
Most recent
May 15, 2026

30d / 90d windows measured from May 15, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 637 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · MOLINA HEALTHCARE, INC.

Annual figures sourced directly from MOLINA HEALTHCARE, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$45.43B
FY2025+12% YoY
Net income
$472M
FY2025-60% YoY
EPS (diluted)
$8.92
FY2025-56% YoY
Free cash flow(?)
-$636M
FY2025-217% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for MOLINA HEALTHCARE, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Maverick CapitalQ2 2026open$185$178-4%
Point72 Asset ManagementQ1 2026open$136$185+36%
Scion Asset ManagementQ4 2025open$147$185+26%
Citadel AdvisorsQ3 2025open$160$185+16%
Viking Global InvestorsQ3 2025Q4 2025$160$138-14%
Point72 Asset ManagementQ3 2025Q4 2025$160$138-14%
Two Sigma InvestmentsQ1 2025open$272$185-32%
Point72 Asset ManagementQ4 2024Q1 2025$306$272-11%
Citadel AdvisorsQ3 2024Q2 2025$339$314-7%
Two Sigma InvestmentsQ3 2024Q4 2024$339$306-10%
D.E. ShawQ3 2024open$339$185-45%
AQR Capital ManagementQ3 2024open$339$185-45%
Millennium ManagementQ3 2024open$339$185-45%
Scion Asset ManagementQ3 2024Q2 2025$339$314-7%
Renaissance TechnologiesQ3 2024open$338$185-45%
Maverick CapitalQ2 2024Q4 2024$346$306-12%
Bridgewater AssociatesQ1 2023open$299$178-41%
Maverick CapitalQ4 2022Q4 2023$315$363+15%
Bridgewater AssociatesQ2 2022Q3 2022$296$328+11%
Maverick CapitalQ3 2021Q2 2022$253$304+20%
Maverick CapitalQ4 2020Q2 2021$219$262+20%
Glenview CapitalQ2 2020Q1 2022$181$308+70%
Maverick CapitalQ2 2020Q3 2020$181$194+7%
Coatue ManagementQ1 2020Q2 2020$145$181+25%
Viking Global InvestorsQ4 2019Q3 2023$122$320+163%
Maverick CapitalQ2 2019Q4 2019$130$122-6%
Maverick CapitalQ4 2018Q1 2019$127$136+7%
Viking Global InvestorsQ3 2017Q2 2018$58$85+48%
JANA PartnersQ3 2017Q2 2018$58$85+48%
Viking Global InvestorsQ4 2014Q1 2015$49$60+24%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.